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Background: Human amniotic fluid cells (hAFCs) may differentiate into multiple cell lineages and thus have a great
potential to become a donor cell source for regenerative medicine. The ability of hAFCs to differentiate into germ
cell and oocyte-like cells has been previously documented. Herein we report the potential use of hAFCs to help
restore follicles in clinical condition involving premature ovarian failure.
Results: Human amniotic fluid was obtained via amniocentesis, yielding a subpopulation of cloned hAFCs that was
able to form embryoid bodies (EBs) and differentiate into three embryonic germ layers. Moreover, culture of EBs in
medium containing human follicular fluid (HFF) or a germ cell maturation factor cocktail (FAC), expressed germ cells
markers such as BLIMP1, STELLA, DAZL, VASA, STRA8, SCP3, SCP1, and GDF9. Furthermore, one cell line was grown from
clone cells transfected with lentivirus-GFP and displaying morphological characteristics of mesenchymal cells, had the
ability to restore ovarian morphology following cell injection into the ovaries of mice sterilized by intraperitoneal
injection of cyclophosphamide and busulphan. Restored ovaries displayed many follicle-enclosed oocytes at all stages
of development, but no oocytes or follicles were observed in sterilized mice whose ovaries had been injected with
medium only (control). Notably, identification of GFP-labeled cells and immunostaining with anti–human antigen-
specific antibodies demonstrated that grafted hAFCs survived and differentiated into granulosa cells which directed
oocyte maturation. Furthermore, labeling of ovarian tissue for anti-Müllerian hormone expression, a functional marker
of folliculogenesis, was strong in hAFCs-transplanted ovaries but inexistent in negative controls.
Conclusion: These findings highlight the possibility of using human amniotic fluid-derived stem cells in regenerative
medicine, in particular in the area of reproductive health.
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Premature ovarian failure (POF) is a defect characterized
by the premature depletion of ovarian follicles. Approxi-
mately 1% and 0.1% of women under 40 and 30 years of
age, respectively, experience POF. While at present about
25% of all forms of POF can be classified as iatrogenic and
related to cancer treatment, more than 50% of the cases re-
main idiopathic [1,2]. Most women with POF are infertile
and suffer unexpected early-onset menopausal symptoms.
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reproduction in any medium, provided the ora specific tissue cell line under defined incubation condi-
tions [3]. Therefore stem cell therapy may potentially pro-
vide an avenue to treat women with POF, reproductive
aging and/or poor oocyte quality. In this regard embryonic
stem (ES) cells have been proposed as a useful model for
studying germ cell development. For instance, human ES
cells spontaneously expressed germ cell markers during
their differentiation into embryoid bodies (EBs) [4]. More-
over, murine and human ES cells differentiated into germ-
line cells, underwent meiosis and produced sperm or
oocytes, respectively [5,6]. Regarding the regulation of
germ cell development, it was found that DAZL (deleted
in azoospermia-like, DAZL) gene expression played a pri-
mary role in the differentiation of ES cells into primordial
germ cells [7,8]. Nonetheless, while Dazl expression wasThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in vitro, this only supported progression through the early
stages of meiosis. Thus completion of meiosis required
mixing ES cells with minced ovarian tissue and grafting
under the kidney capsule of ovariectomized recipient mice
to obtain oocytes, albeit at a very low efficiency [9]. Con-
siderable work remains to further define the requirements
for in vitro differentiation of ES cells into mature gametes
so that these techniques can be clinically applied in
regenerative reproductive medicine protocols.
In addition, given the difficulties in growing embryos to
obtain human embryonic stem cells, amniotic fluid may be
regarded as an alternate source of pluripotent stem cells.
Human amniotic fluid contains multiple fetus-derived cell
types that possess self-renewal and pluripotency properties.
Hence, human amniotic fluid stem cells (AFSCs) have
a great potential to become a donor cell source of choice
for regenerative medicine [10]. Moreover, human AFSCs
display several advantages over ES cells in regards to
pluripotency and proliferation rate. For instance, human
AFSCs grew extensively in culture and were induced to dif-
ferentiate into cell types representing different germ layers,
that is, into osteogenic, chondrogenic, adipogenic, renal,
hematopoietic or neurogenic cell lineages [11]. Further-
more, hAFCs expressed DAZL [12], suggesting potential
ability to differentiate into germ cell lineage cells. Recently,
Cheng et al. reported that human amniotic fluid stem cells
cultured in medium containing 5% porcine follicular fluid
can differentiate into oocyte-like cells [13].
In this study, we characterized the expression of stem
and germ cell markers in undifferentiated hAFCs and ob-
served that germ cell marker expression could be induced
in vitro in hAFCs-derived embryoid bodies (EB). Then, to
test the functional ability of such cells in vivo, GFP-
transfected hAFCs were transplanted into the ovaries of
chemically-sterilized mice. Altogether, we highlight a new
possibility for using human amniotic fluid cells in regene-
rative medicine in the area of reproductive health.
Methods
Amniotic fluid, follicular fluid and oocyte sample collection
All amniotic fluid cell samples were obtained via amnio-
centesis performed after the 18th week of pregnancy for
routine prenatal diagnosis. The indications were ad-
vanced maternal age, a familial or personal history of
birth defects, or any foreseen risk of the fetus carrying a
chromosomal anomaly or inherited condition. The cyto-
genetic analyses revealed normal karyotypes for all do-
nors. The mean maternal age was 36 years, with a range
of 33–38 years of age, and the mean gestational age was
19 weeks, with a range of 16–22 weeks. Samples of fol-
licular fluid (5 ml) were separately collected from three
women (range 29–40 years of age) who were undergoing
oocyte pick up for in vitro fertilization and embryotransfer (IVF-ET) to overcome male factor infertility.
Ten GV oocytes with fertilization failure were collected
from four women (range 32–40 years of age) who were
undergoing IVF-ET. This study was carried out with the
approval of the Ethics Committee of the International
Peace Maternity and Child Health Hospital, Shanghai
Jiaotong University, Shanghai, China, and informed
consents were obtained from all donors.
Preparation of follicular fluid
Three samples of follicular fluid (5 ml each) were mixed,
pooled and centrifuged at 4000 g for 5 min. The super-
natant was filtered (0.22 μm pore size) to eliminate con-
taminating cells potentially present in follicular fluid,
aliquoted and stored at −20°C until use. All experiments
were performed with the same batch.
Human amniotic fluid cell culture and differentiation
Amniotic fluid samples were centrifuged individually at
4000 × g for 5 minutes at room temperature and the
supernatant was discarded. Cellular components were
grown in DMEM/F12 medium (Gibco, Grand Island,
NY, USA) containing 15% ES-FBS (Gibco, Grand Island,
NY, USA), 1% glutamine and 1% penicillin/streptomycin
(Gibco, Grand Island, NY, USA), supplemented with
bFGF (4 ng/ml, Invitrogen, Carlsbad, CA, USA) at 37°C
in a 5% CO2 atmosphere. After expansion to confluence
(5–7 d), AFSCs formed clones. Then, some clones were
used to prepare a single cell suspension by gentle tryp-
sinization. In addition, some clones were picked up and
cultured under standard EB media supplemented with
5% human follicular fluid for 7–14 days to promote EB
formation. Then, EBs were maintained in differentiation
medium which contain germ cell maturation factor cock-
tail (FAC) [9] for 7–14 days by replacing half the medium
every 3–4 days. The FAC medium consisted of standard
EB media supplemented with a germ cell factor cocktail
containing: human SCF 100 ng/ml, SDF1 20 ng/ml, bFGF
20 ng/ml, BMP4 50 ng/ml (all R&D Systems, Minneapolis,
Minnesota, USA), N-acetylcysteine 1 mg/ml, forskolin
5 mM, retinoic acid 1 mM (all Sigma, St. Louis, Missouri,
USA) and CYP26 inhibitor R115866 1 mM (Johnson &
Johnson, Brunswick, New Jersey, USA).
RNA extraction and real-time qPCR analysis
Total RNA extraction from samples was performed using
the RNeasy Mini Kit (Qiagen, Chataworth, CA, USA). Five
hundred ng of total RNA from each sample was used in
reverse transcription (RT) using the iScript cDNA synthe-
sis kit (Bio-Rad, Hercules, CA, USA). Real-time RT-qPCR
was carried out on cDNA using IQ SYBR Green (Bio-Rad,
Hercules, CA, USA) on the Mastercycler ep realplex
(Germany). All reactions were performed in a 25-μl vo-
lume according to the kit. Primer sequences are listed in
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lows: 1) for ZPA, ZPC, GDF9, STELLA, STRA8, and
DAZL 94°C for 2 min, then 94°C for 30 sec, 60°C for
30 sec, 72°C for 45 sec, 28 cycles, then 72°C for 10 min;
for OCT4, CD133, CD117, HLA-DR, BLIMP1, VAZA,
SCP1, SCP3, 18 s RNA, 94°C for 2 min, then 94°C for
30 sec, followed by 28 cycles at 53°C for 30 sec and 72°C
for 45 sec, finalizing at 72°C for 10 min; and, 2) for
NANOG and cMOS, 94°C for 2 min, then 94°C for 30 sec,
followed by 28 cycles at 60°C for 30 sec and 72°C for
45 sec, and finalizing at 72°C for 10 min. The amplification
efficiency of different genes was determined relative to
18sRNA (ΔC t = Ctgene-Ct18sRNA). The quantity of
mRNA in each sample was calculated by the comparative
(ΔΔCt = ΔCtgene-ΔCtcontrol) value method. The fold change
in gene expression relative to the control was calculated
by 2-ΔΔCt [14]. Data were obtained by averaging the
results from three independent experiments.
Flow cytometry
The expression of OCT4 and CD117 was evaluated on
both single cell suspensions obtained from hAFCs as well
as on cells from EBs. A total of 1 × 106 Cells were
suspended in 2% BSA/PBS and labeled with the corre-
sponding antibodies, as follows: 1) mouse anti-human
OCT3/4 conjugated with Alexa Fluor 488 (eBioscience,
San Diego, CA, USA) and 2) mouse anti-human PE-
labeled CD117 (eBioscience, San Diego, CA, USA). Identi-
fication of Oct4+ and CD117+ cells was performed using
a FC500 flow cytometer (Beckman Coulter, Miami, FL,
USA) and analyzed by Beckman Coulter CXP software.
Animals
Forty six-week-old C57BL/6 females were prepared as
sterilized recipients by intraperitoneal injection of busul-
fan (30 mg/kg; resuspended in DMSO) and cyclophospha-
mide (120 mg/kg resuspended in DMSO) once and were
observed for 1 week. Five age-matched females injected
with DMSO only were used as non-sterilized controls. All
animal procedures were approved by the Institutional Ani-
mal Care and Use Committee of Shanghai, and were
performed in accordance with the National Research
Council Guide for Care and Use of Laboratory Animals.
Transfection and transplantation of human amniotic
fluid cells
Once hAFCs had grown to a density of 80–90%, lentivirus
vector with enhanced green fluorescent proteinlenti-EGFP
(a gift from Tianjin Liu [15]) was added to cultured cells
and incubated at 37°C in a 5% CO2 atmosphere for 24 h.
Titration of concentrated supernatants was performed by
serial dilutions of vector stocks on 1 × 105 Hela cells
followed by fluorescence-activated flow cytometry analysis
according to the formula: 1 × 105 Hela cell × % EGFPpositive cells × 1000/μl virus. Titers of lentiviral vectors
were 1 × 108 - 1 × 109 TU/ml. After growing for another
2 days, hAFCs were examined by fluorescence microscopy.
The overall cell transfection rate was determined to be
greater than 95%. After lentiviral infection for 2 days,
hAFCs were washed three times and trypsinized (0.25%
trypsin), neutralized in 10% FBS, washed in PBS and
resuspended in the culture medium. Recipients were anes-
thetized by an intraperitoneal injection of pentobarbital
sodium (45 mg/kg body weight). Approximately 6 μl of a
single-cell suspension, containing 2–5 × 103 cells (n = 30),
or 6 μl of culture medium for control (n = 10), was
injected into both ovaries of the sterilized recipient.
Microinjection of each ovary was performed as previously
described according to Zou et al. [16].
Immunohistochemical analysis
Two months following ovary injection, recipient and con-
trol mice were euthanized by cervical dislocation. Ovaries
were dissected and fixed in 4% paraformaldehyde (4°C,
overnight), dehydrated through a graded series of ethanol,
vitrified in xylene, and embedded in paraffin. Six-μm thick
sections were fixed for 5 minutes in 10% buffered for-
malin, after which endogenous peroxidase activity was
quenched by incubating the sections in 0.3% hydrogen
peroxide in methanol for 30 minutes. Different sections
were then incubated in the presence of the following anti-
bodies: mouse anti-human mitochondria (1:300; mono-
clonal antibody, EMD Millipore, Billerica, Massachusetts,
USA); mouse anti-human nuclei (1:100; human nuclei,
EMD Millipore, Billerica, Massachusetts, USA); mouse
anti-human follicular stimulating hormone receptor
(FSHR; 1:100; Abcam, Cambridge, UK); mouse anti-
human anti-mullerian hormone (AMH; 1:30 AbD
Serotec, Kidlington, Oxford, UK). A peroxidase kit
(Vector Laboratories, Burlingame, CA, USA) was used fol-
lowing the manufacturer’s manual. Peroxidase substrate was
developed using the DAB (3,39-diaminobenzidine) substrate
kit (Vector Laboratories). Slides were counterstained with
hematoxylin QS (Vector Laboratories) and were either
mounted with low viscosity aqueous mounting medium
(Scytek Laboratories, Logan, UT, USA) or dehydrated and
mounted with VectaMount Permanent Mounting Medium
(Vector Laboratories).
Immunofluorescence staining
Both individual hAFCs and EBs in suspension were fixed
in 4% paraformaldehyde for 15 to 20 min at room
temperature, and then washed twice (10 min each) with
1 × PBS. Cells were permeabilized with 0.1% Triton X-100
for 10 min at room temperature, and then washed twice
with 1 × PBS. After blocking in 10% skim milk solution for
30 min, cells were incubated with the anti-OCT-4A (rabbit
anti-human; 1:200; Santa Cruz, CA, USA), anti-Blimp1
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DAZL (goat anti-human; 1:500; Santa Cruz, CA, USA),
anti-STELLA (goat anti-human 1:200, Santa Cruz), anti-
ZPC (rabbit anti- human; 1:200; Santa Cruz, CA, USA), or
anti-SCP3 (rabbit anti-human; 1:800; Abcam, Cambridge,
UK) antibodies, for 1 h, at room temperature.
Ovaries from recipient and control mice were fixed with
the Tissue-Tek® OCT7™ Compound (Sakura Finetek Mid-
dle East, Dubai, United Arab Emirates) and sliced in 5-μm
thick sections. Slides were washed twice with PBS and
kept in blocking solution for 30 min at room temperature.
Slides were then incubated with rabbit polyclonal anti-
GFP (1:200; Chemicon, Billerica, Massachusetts, USA)
at 4°C, overnight.
Cells or sections were washed three times with 1 ×
PBS, and probed with FITC-labeled IgG (1:200, Santa
Cruz, CA, USA). Fluorescence images were taken using
a Leica DMI3000 microscope (Wetzlar, Germany).
Statistical analysis
Means for relative gene expression were compared by
ANOVA using Microsoft Excel software. Statistical sig-
nificance was set at P < 0.05.
Results
The expression level of stem cell and germ cell markers in
undifferentiated human amniotic fluid cells
To examine germ cell-specific genes in hAFCs, six inde-
pendent samples obtained via amniocentesis were cul-
tured for one week and a portion of the grown cells
were assayed. Real-time qPCR was used to assess gene
expression in comparison to human embryonic stem
cells (hES; positive controls for stem cells), human
oocytes (positive controls for germ cells), and human
skin fibroblast cells (hSFCs; negative controls for
pluripotency markers). As expected [17,18], all hAFCs
samples consistently expressed OCT4, albeit at rela-
tively lower levels than hES. Cells originating from am-
niotic fluid samples also expressed the hematopoietic
stem cell marker CD133. However, the expression of
the major histocompatibility complex (MHC) Class II
HLA-DR was low in all groups (Figure 1A). These re-
sults were consistent with amniotic fluid samples yield-
ing a population of pluripotent cells, given that OCT4
expression is restricted to pluripotent ES cells [19,20].
Then, we examined the expression of germ cell-specific
genes in hAFCs as compared with human oocytes. These
genes included: B-lymphocyte-induced maturation protein
1 (BLIMP1), STELLA and deleted in azoospermia-like
(DAZL), which are known to be expressed in PGCs
through later stages of germ cell differentiation; VASA
which is known to be expressed during gonocyte forma-
tion; stimulated by retinoic acid 8 (STRA8), synaptonemal
complex protein 1 and 3 (SCP1, SCP3), moloney sarcomaoncogene (c-MOS), zona pellucida (ZP) gene family (ZPA,
ZPC) which are expressed during meiosis; and, growth
and differentiation factor 9 (GDF9), which is an adult
oocyte-specific marker [21]. Among the pre-meiotic and
meiotic germ cell gene markers, STELLA and SCP1, SCP3
were highly expressed in all six hAFCs samples compared
with human skin fibroblast cells, whereas the expression
of other same-stage markers (DAZL, VASA, GDF9), dis-
played high variability among samples. Conversely, the ex-
pression of STRA8, c-MOS and ZPC was consistently
lower in hAFCs samples. Overall, the expression level of
the germ cell specific genes was relatively low compared
to that in mature oocytes (Figure 1B).
Consistent with the transcriptional profiles, mature oo-
cytes expressed germ cell proteins, including OCT4A,
BLIMP1, DAZL, STELLA, ZPC and SCP3 (Figure 1C).
However, as evidenced by immunofluorescence, OCT4
protein expression was only detectable in hAFCs
(Figure 1D). Altogether, these data suggest that less germ
cell gene markers are expressed spontaneously in a sub-
population of hAFCs compared to human mature oocytes.
Cultured hAFC colonies have the ability to differentiate
into three embryonic germ cells
Previous work had shown that few cells in human am-
niotic fluid form colonies under routine cell culture
conditions, and while most of the cells in amniotic fluid
have the capacity to attach, they do not proliferate or
form colonies because of cell cycle arrest, differen-
tiation status, or senescence [22]. Notably, in this study
we used a stem cell culture system that supported
favorably hAFCs out-growth and that subsequently
yielded EB formation. Hence, hAFCs cultured in
DMEM/F12 medium supplemented with bFGF for 5–
7 days formed clones (Figure 2A-B). Amniotic fluid
samples (3–5 ml) yielded inconsistent cell numbers.
Hence, after 1 week in culture we obtained 104-108
cells and 10–50 clones per amniotic fluid sample.
Clones were digested with accutase (Innovative Cell
Technologies, San Diego, CA, USA) each yielding 100–
200 cells. Flow cytometry was used to assess OCT4 and
CD117 expression in cells stemming from such clones.
Whereas over 7% of the clone cells expressed both
OCT4 and CD117, only 1.8% of the attached differenti-
ated hAFCs were positive for both transcription factors
(P < 0.001, Figure 2C-D).
These clones were also assayed for pluripotency after
resuspension in EB media. We observed hAFC-derived
EB formation to be accompanied by induction of the dif-
ferentiation markers Sox17 (endoderm), muscle actin
(mesoderm) and Nextin (ectoderm) (Figure 2E), which is
agreement with the report of Valli et al. [23]. This de-
monstrates that clones obtained from hAFCs harbor
high differentiation potential.
Figure 1 The expression of stem and germ cell-specific genes in undifferentiated human amniotic fluid cells (hAFCs). (A,B) Quantitative
PCR was used to compare stem cell and germ cell specific gene expression in hAFCs obtained from 6 independent samples, human embryonic
stem cells (hES) and human GV oocytes. Human skin fibroblast cells (hSFC) were used as negative controls and 18 s RNA was used as an internal
housekeeping gene. Results shown represent mean ± standard deviation from three independent experiments. (C) Immunofluorescence analysis
of germ cell-specific genes in human GV oocytes. Scale bars = 50 μm. (D) Immunofluorescence analysis of germ cell-specific genes in
undifferentiated hAFCs. While hAFCs expressed OCT4, expression was negative for BLIMP1, DAZL, STELLA, ZPC and SCP3. Scale bars = 50 μm.
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colones in vitro
In previous studies, the derivation of germ cells relied
on the formation of embryoid bodies (EBs) from ES
cells. Moreover, differentiation of immature oocytes and
sperm from murine and human ES cells in culture has
also been reported [4-6]. To determine whether germ
cell differentiation could be achieved from hAFCs via EBformation, clones were suspended under EB differenti-
ation medium (Figure 2C). The EB-derived cells were
cultured for 1 or 2 weeks in either standard differenti-
ation medium alone or containing a germ cell matu-
ration factor cocktail (FAC) as previously reported [9].
The FAC cocktail comprised antiapoptotic, germ cell
specification and meiotic induction factors, including
bone morphogenetic protein 4 (BMP4), retinoic acid,
Figure 2 Phase contrast photomicrographs of human amniotic fluid cultured cells and spontaneous differentiation of clone cells into
cells of three embryonic germ layers. (A, B) hAFCs formed clones (white arrows) and attached cells (black arrows) after 5–7 days in culture.
(C) Clone cells yielded embryoid bodies (EBs) (black arrow). (D) Scatter plots and bar graph for flow cytometry analysis of OCT4 and CD117
expression in attached cells (hAFC) and clones (hAFC-clone). The percentage of Oct4+/CD117+ expressing cells was higher (7.8%) in clone than
attached cells (1.81%; ***P < 0.001) (** P < 0.01, * P < 0.05). (E) Embryoid bodies spontaneously differentiated into cells stained with Sox17, muscle
actin and Nestin respectively. Magnification, 100x (A), 200x (B, C, E).
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(SDF1), stem cell factor (SCF), and basic fibroblast growth
factor (bFGF). We also tested medium supplemented with
5% human follicular fluid (HFF) to investigate its ability
to induce the derivation of germ line cells.
We had noted from the above experiments that undif-
ferentiated hAFCs did not express germ cell-characteristic
genes. Herein, qPCR was used to evaluate gene expression
in EBs derived from hAFCs and incubated in germ cell dif-
ferentiation conditions. Under standard differentiation
conditions, without FAC or HFF, the expression of OCT4
and NANOG decreased, whereas BLIMP1, STELLA and
STRA8 increased. Notably, the expression DAZL, a gene
that has only been shown to function during germ cell for-
mation and/or maintenance, was undetectable both at the
mRNA and protein level in EB cells under standard diffe-
rentiation conditions (Figures 3A-B). Conversely, EBs cul-
tured in differentiation conditions with FAC or HFF,
displayed increased expression of all BLIMP1, STELLA,
DAZL,VASA, STRA8, SCP3, and c-MOS but decreased ex-
pression of OCT4 and NANOG. In agreement with mRNA
expression levels, immunostaining showed increased pro-
tein expression for BLIMP1, DAZL, STELLA, ZPC and
SCP3 in EBs cultured in FAC or FF-containing medium.
As expected, EBs cultured in basic differentiation medium
only showed increased immunostaining for BLIMP1,
STELLA and ZPC. There was no difference in ZP isoforms
mRNA (ZPC, ZPA) or protein (ZPC) expression before
and after incubation in germ cell-inducing conditions. The
expression of the meiotic factor synaptonemal complex
protein-3 (SCP3) was only detected in EBs induced by FAC
or HFF (Figures 3A-B). Altogether, these results are con-
sistent with both HFF and FAC inducing germ cell diffe-
rentiation of hAFC-derived EBs.Mesenchymal-like hAFCs can restore morphologically
chemotherapy-damaged ovaries
One hAFC line was established from clone cells derived
from one sample. Interestingly, the cell morphology mi-
micked that of mesenchymal cells rather than the typical
epithelial morphology of human amnion epithelial cells
(hAECs; Figure 4A-B). To further characterize this hAFC
line, real-time PCR was used to assay for gene expression
of epithelial and mesenchymal cell markers. Compared
with hAECs, hAFCs cells derived herein expressed high
levels of mesenchymal markers, such as zinc finger E-box
binding homeobox 1 (ZEB1), twist basic helix-loop-helix
transcription factor (Twist), Vimentin and N-cadherin;
conversely, hAFC did not express the epithelial marker
E-cadherin (Figure 4C). Karyotype analysis revealed a nor-
mal chromosomal complement (46, XX; Figure 4D).
Thus these mesenchymal-like cells were used for the
transplantation study. To examine the physiological func-
tion of hAFCs in vivo, wild-type female mice were sterilized
by intraperitoneal pre-treatment with cyclophosphamide
and busulphan (n = 40) in order to destroy the existing pre-
and post-meiotic germ cell pools [24,25]. Once hAFCs cells
had grown to 85% density, they were transfected with
lentivirus-GFP (Figure 5A-B). After one week culture,
2–5 × 103 hAFCs were transplanted into both ovaries of the
above sterilized recipient mice (n = 30). In addition, control
sterilized mice (n =10) were also transplanted with culture
medium containing no hAFCs. No transplant-related
deaths occurred. Two months following hAFCs transplan-
tation, ovaries were collected and assayed for the presence
of oocytes as determined by their morphological appea-
rance and GFP expression. Upon histological evaluation,
ovaries injected with hAFCs presented numerous oocytes
at all stages of development (Figure 5E-F), similar to the
Figure 3 Gene expression level of germ cell markers in embryoid bodies (EBs) derived from hAFCs and then cultured further for 1 or
2 weeks (1 w, 2 w). (A) EBs cultured under standard differentiation conditions, cultured in a differentiation conditions with the addition of a
germ cell maturation factor cocktail (FAC) or cultured in human follicular fluid (HFF)-containing differentiation medium. EBs not exposed to
differentiation conditions were used as negative controls for gene expression; 18 s rRNA was used as an internal housekeeping gene. Data
represents means ± SE of 3 independent experiments. (B) Immunofluorescence analysis of cellular and subcellular protein expression for germ cell
markers in embryoid bodies (EBs) derived from cultured human amniotic fluid cells (hAFCs). EBs were cultured for 1 week in basic differentiation
medium, germ cell maturation factor cocktail (FAC)-supplemented differentiation medium or human follicular fluid (HFF)-supplemented differentiation
medium Scale bars = 100 μm.
Lai et al. BMC Developmental Biology 2013, 13:34 Page 7 of 13
http://www.biomedcentral.com/1471-213X/13/34ovaries of non-sterilized mice (n = 5; Figure 5C). Following
transplantation, 50% (5/10 mice) of ovaries displayed GFP-
positive fluorescence. Interestingly, GFP-positive cells were
detected in ovarian tissue nearing oocytes as well as in cells
immediately surrounding oocytes (Figure 5G-R). Con-
versely, two months after sterilization, immature oocytes
or follicles were not detected in medium-injected ovaries
from control recipients (n = 10, Figure 5D). Furthermore,
control ovaries (sterilized but untreated ovaries) comprised
stromal and interstitial cells, as well as a few atretic follicles
lacking GFP expression (Figure 5S-U), consistent with
chemotherapy having destroyed oocytes or ovarian follicles.
Altogether, these findings were consistent with hAFCs
transplantation restoring folliculogenesis in chemically-
damaged murine ovaries.Implanted hAFCs infiltrate the chemically-damaged
murine ovarian tissue and restore ovarian function
Human-specific antigens, including human nuclei antigen
[26] and human follicle - stimulating hormone receptor
(FSHR) [27] were further used as tracking markers for
transplanted hAFCs. To confirm whether GFP-positive
cells in recipient ovaries were indeed derived from grafted
hAFCs, we performed double-staining with GFP and hu-
man specific nuclei antigen in recipient ovarian sections
two months following hAFCs transplantation. Results
showed that GFP positive staining did co-localize with hu-
man anti–nuclei staining in ovarian stroma (Figure 5G-L)
or in antral follicles (Figure 5M-R).
To assess the survival and differentiation of the grafted
hAFCs, the expression of human nuclei antigen was
Figure 4 Characterization of cell type in a human amniotic fluid cell (hAFC) line grown from one sample obtained via amniocentesis.
(A) The hAFCs displayed morphology typical of mesenchymal cells. (B) Human amnion epithelial cells (hAEC) grown in culture for comparison.
(C) Comparison of relative gene expression levels for mesenchymal and epithelial markers relative to 18S RNA; Compared with hAECs, hAFCs cells
expressed high levels of mesenchymal markers, such as zinc finger E-box binding homeobox 1 (ZEB1), Twist, Vimentin and N-cadherin; conversely,
hAFC did not express the epithelial marker E- cadherin. (D) Karyotype analysis showed a normal chromosomal complement (46,XX) in hAFCs
grown herein. Magnification, 100x (A), 200x (B).
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man nuclei expression was detected mainly around the
oocytes in antral follicles, similar to the pattern observed
for GFP expression (Figures 6Ab-c and 5M-R). These re-
sults suggest that hAFCs-derived cells infiltrated the
chemically-damaged murine ovarian tissue and differen-
tiated into the somatic but not the germ cell population.
Hence, human FSHR, a granulosa cell marker required
for normal ovarian development and follicular matu-
ration, was used to further characterize the grafted cells.
Interestingly, FSHR could be detected in cells around
oocytes, similar to the expression pattern observed with
human nuclei (Figure 6Ae-f ). Altogether, these results
support the notion that a portion of hAFCs integrated
into the ovarian niche of sterilized mice and differenti-
ated into granulosa cells.
Anti-Müllerian hormone (AMH) is a protein expressed
by granulosa cells that controls the formation of primary
follicles by inhibiting excessive follicular recruitment by
FSH. Thus AMH levels are strongly correlated with the size
of the follicle pool, and can be used as a marker for ovarian
aging, responsiveness and pathophysiology [28]. As shown
in Figure 6Ba, AMH expression was strong in granulosa
cells of preantral and small antral follicles, and gradually di-
minished in subsequent stages of follicle development in
control ovaries from non-sterilized mice. Conversely, AMH
was no longer expressed in ovaries from mice sterilized by
chemotherapy (Figure 6Bb) but reappeared in ovarian folli-
cles from sterilized mice when evaluated at 2 months
following hAFC transplantation (Figure 6Bc-d).Altogether, the above presented results suggest that
hAFCs integrated into the ovaries of infertile mice and
participated in oocyte regeneration. Thus ovarian func-
tion can be at least partially restored following hAFC
transplantation.
Discussion
While ES cells provide a potential avenue for germ cell
regeneration in reproductive medicine, their preparation
and use still presents many challenges as well as ethical
concerns. As an alternative, cells derived from human
amniotic fluid (hAFCs), have been shown to exhibit high
differentiation potential and high proliferative activity,
both characteristics of stemness. Moreover, hAFCs ex-
press the stem cell marker OCT4 [9,18,29-32] and can
differentiate into cells of all three embryonic tissue layers
[9,29-32]. For instance, hAFSCs descending from one
single OCT4- and NANOG-positive line were induced
to undergo adipogenic, osteogenic and neurogenic diffe-
rentiation [33]. Similarly, monoclonal AFSCs expressing
the markers OCT4 and CD117 (c-kit), could be induced
to differentiate into adipogenic, osteogenic, myogenic,
endothelial, neurogenic and hepatic cell lineages [11].
Therefore, hAFCs have great potential to become an im-
portant source of stem cells for use both in basic re-
search as well as for regenerative medicine purposes.
Herein we report the potential of cloned-hAFCs to ex-
press germ cell markers in vitro, and the potential of
hAFC line derived from cloned- hAFCs to support fol-
licle and oocyte development in vivo (Figure 7).
Figure 5 Transplantation of a line of GFP-transfected human amniotic fluid-derived cells (hAFCs) into chemotherapy-sterilized recipient
mice. (A) hAFC cell line derived from clone cells grown to 85% density. (B) GFP-transfected hAFCs. (C-F) Representative H&E micrographs of ovary
sections from: (C) non-sterilized normal control mice. (D) Sterilized non-transplanted mice after a 2 month-recovery period showing stroma, and atretic
primordial or primary follicles. (E, F) sterilized recipient mice following transplantation of hAFCs; arrows indicate follicles at various stages of
maturational development. Sections display primordial (E), as well as primary and large antral follicles (F). (G-R) Immunofluorescence of ovarian
sections from sterilized mice 2 months after transplantation with GFP-transfected hAFCs. (G-I) GFP staining is observed in ovarian stroma. (M-O)
Follicles containing GFP-positive (green) oocytes. Blue: DAPI immunofluorescence. (S-U) Culture-medium injected ovaries in control sterilized mice lack
GFP signal following a 2-month recovery period. (G-R) Double-staining with GFP and human nuclei antigen were performed to look for the derivation
of GFP positive cells in recipient ovaries 2 months after hAFCs transplantation. (G-L) Ovarian sections stained with GFP and anti–human nuclei
antibody revealing grafted hAFCs in stroma. (M-R) GFP staining was co-locolized with human nuclei antigen in antral follicles of recipient ovaries after
hAFCs transplantation for 2 months. Scale bars = 50 μm (A, B, D, E, S-U); 100 μm (G-R); 200 μm (C, F).
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of germ cell markers; in agreement to previous reports
[11], we observed a consistently high expression of
OCT4 and CD133. However, when we examined add-
itional markers we did not observe expression of genes
specific to germ cell differentiation. In this regard, it was
reported that hAFCs had the ability to form embryoid
bodies (EBs) when cultured under conditions without
anti-differentiation factors and without contact to feeder
cells. Moreover, the formation of such three-dimensional
multicellular aggregates was accompanied by a decrease in
stem cell marker expression and by the induction of diffe-
rentiation into different cell lineages [23]. Hence herein
hAFCs kept under a stem cell culture system yielded a
high number of clones that when cultured in suspension
without anti-differentiation factors, spontaneously formedmulticellular EBs and harbored high differentiation po-
tential. Moreover, when we cultured EBs in the presence
of germ cell maturation FAC [9] or 5% HFF, we were
able to induce expression of markers consistent with
germ cell differentiation.
Indeed, both the germ cell maturation FAC as well as
HFF appeared to share factors that could potentially in-
duce the differentiation of human amniotic fluid-derived
stem cells into germ cell lineage cells. For instance, HFF,
which is produced during folliculogenesis, contains fac-
tors that are secreted from granulosa and theca cells, as
well as oocytes [33,34]. Many growth factors and hor-
mones such as activin A, follistatin, SCF, bFGF, AMH
and estrogen have been isolated from follicular fluid
[35,36]. In fact, some of these factors, such as SCF and
bFGF are also components of the germ cell maturation
Figure 6 Grafted hAFCs infiltrate the chemically-damaged murine ovarian tissue and restore ovarian function. (A) Immunohistochemistry for
human-specific antigens detecting grafted cells resulting from transplantation of human amniotic fluid cells into the ovaries of chemically-sterilized
mice. (a) Sample for human nuclei antigen-negative ovarian section following hAFC transplantation. (b, c) Human nuclei antigen expression in
recipient ovaries 2 months after hAFCs transplantation. (d) Sample for human follicle stimulating hormone receptor (FSHR)-negative ovarian section
following hAFCs transplantation. (K, L) Human FSHR expression in recipient ovaries 2 months after hAFCs transplantation. Arrows indicate positive
expression of human nuclei or human FSHR in the oocyte, while the other granulosa cells served as negative controls. Scale bars = 100 μm. (B)
Immunohistochemistry for anti-mullerian hormone (AMH) in ovarian sections from mice. (a) AMH is expressed in the granulosa cells of primary,
preantral and small antral follicles in ovaries from control fertile mice. (b) AMH expression disappears in the ovaries of chemically-sterilized mice
examined 2 months following hAFC-free medium transplantation. (c, d) AMH expression reappears in ovaries from chemically sterilized mice when
examined at 2 months following hAFC transplantation. Scale bars = 200 μm
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the regulation of follicular development are well docu-
mented [37,38]. Furthermore, previous research had de-
monstrated that 5% porcine follicular fluid could induce
porcine skin-derived stem cells to form germ cells [39].
Our research further supported these notions in that both
HFF and FAC-supplemented media efficiently induced
hAFCs to express germ cell-specific genes and hence
direct them to enter the germ cell path of differentiation.
While several studies have demonstrated that human ES
cells can be induced to differentiate into somatic and germ
cell lineages, including germ cell precursors or PGCs
[40,41], germ cell differentiation has been largely limited
to the earliest stages. Therefore, ES cell-derived oocyte
maturation ultimately fails in vitro [42-44]. Nicholas et al.
transplanted ES cell-derived germ cell co-aggregated withwild type newborn ovarian tissue into the kidney capsule
of recipient mice and found that the ovarian niche could
direct functional maturation of these germ cells [9]. Simi-
larly, isolated female germline stem cells from neonatal
mouse ovaries underwent oogenesis and resulted in off-
spring when transplanted into ovaries of infertile mice
[16]. Hence we hypothesized that hAFC-derived stem
cells might differentiate into follicles and hence restore
folliculogenesis after transplantation to the appropriate
niche, that is, into chemically-damaged ovaries. Thus,
we established one hAFC line derived from clone cells
of one sample, and used for ovarian transplantation.
In order to follow these cells through development,
hAFC line were transfected with lentivirus-GFP prior to
transplantation. Indeed, GFP-positive cells integrated into
the ovarian niche of infertile mice and this was further
Figure 7 The flow diagram of hAFCs restoring ovarian function.
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expression, including human nuclei and FSHR in recipient
ovaries. Folliculogenesis depends not only on the circulating
levels of the gonadotropins but also on the expression of
gonadotropin receptors by follicular cells in the ovary. Be-
cause human FSHR, which has been localized to granulosacells of Graafian follicles [27] was expressed in the ovaries
from sterilized mice, this strongly suggested that grafted
hAFCs differentiated into granulosa, but not germ cells.
Moreover, immunofluorescence detected the expression of
human-specific antigens only in the population of follicular
supporting cells. Hence, these results strongly support the
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the chemically-damaged murine ovary. Notably, increased
expression of AMH, a hormone strongly correlated with
the size of the follicular pool [28,45,46], was marked after
hAFCs transplantation in the ovaries of sterilized mice.
Conversely, AMH expression is negative in the control
groups, further supporting a role of hAFC transplantation
in restoring ovarian function in infertile mice.
Interestingly, not all transplanted ovaries from sterilized
mice developed GFP(+) or human antigen-positive cells, but
we also identified GFP(−) and human antigen-negative fol-
licular growth. These findings suggested that in these cases
transplanted hAFCs may have aided in folliculogenesis re-
covery via indirect trophism on ovarian tissue. This is con-
sistent with studies spanning other organs where improved
functionality was observed not due to cell differentiation
but to mere supportive effects on existing cells [47,48].
Worth noting, amniotic fluid-derived cell clones
displayed a normal karyotype and no evidence of tumori-
genic effect in vivo (Data not shown). In agreement, it was
previously reported that hAFCs are genomically stable and
harbor neither epigenetic memory nor somatic mutations
of already differentiated source cells [11,29-32]. Moreover,
compared to ES cells, there is no ethical and religious con-
cerns associated with hES cells which require the destruc-
tion of human embryos [49]. In addition, another
promising renewable source of pluripotent cells is consti-
tuted by induced pluripotent stem cells (iPSCs), which are
obtained from reprogrammed somatic cells using defined
factors. However, iPSCs can induce a T-cell-dependent im-
mune response in syngeneic recipients [50]. In this regard,
work from others revealed that amniotic fluid-derived cells,
hold immunosuppressive properties [51] making them even
more attractive for their potential clinical applications.
Conclusions
This study demonstrated hAFCs obtained from early second
trimester stages of fetal development may hold the intrinsic
ability to express germ cell markers in vitro and restore
folliculogenesis in a germ cell-ablated mouse model. The
methods outlined above may provide a platform to elucidate
the mechanisms of ovarian function restoring. Altogether,
our findings have implications for the future use of stem cells
in the treatment of POF and aging-related infertility.
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